Evidence of the Effectiveness of Breast Cancer Screening

  • Jocelyn Chamberlain
  • Domenico Palli
Conference paper
Part of the ESO Monographs book series (ESO MONOGRAPHS)

Abstract

Because screening is offered by the medical profession to supposedly well women in the general public, there is a particular ethical responsibility to be certain that it is effective in its implicit purpose of saving lives, and that the level of benefit it offers outweighs its costs and disadvantages to the women concerned. A large amount of research has therefore been undertaken to measure the value of screening for breast cancer.

Keywords

Toxicity Europe Tamoxifen Hone Paci 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shapiro S, Venet W, Strax P, Venet L: Periodic screening for breast cancer. In: The Health Insurance Plan Project and Its Sequelae, 1963–1986. John Hopkins University Press, Baltimore & London 1988Google Scholar
  2. 2.
    Shapiro S, Strax P, Venet L: Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 1971 (215):1777–1785PubMedCrossRefGoogle Scholar
  3. 3.
    Tabar L, Fagerberg G, Duffy SW, Day NE: The Swedish Two-County trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989 (43): 107–114PubMedCrossRefGoogle Scholar
  4. 4.
    Andersson I, Aspegren K, Janzon L et al: Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. Br Med J 1988 (297):943–994CrossRefGoogle Scholar
  5. 5.
    Roberts MM, Alexander FE, Anderson TJ et al: Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990 (335):241–246PubMedCrossRefGoogle Scholar
  6. 6.
    Frisell J, Eklund G, Hellstrom L et al: Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991 (18):49–56PubMedCrossRefGoogle Scholar
  7. 7.
    Moss SM, Draper GJ, Hardcastle JD, Chamberlain J: Calculation of sample size in trials for early diagnosis of disease. Int J Epidemiol 1987 (16):104–110PubMedCrossRefGoogle Scholar
  8. 8.
    UK Trial of Early Detection of Breast Cancer. Breast cancer mortality after ten years in the UK Trial of Early Detection of Breast Cancer (submitted)Google Scholar
  9. 9.
    Calnan MW, Chamberlain J, Moss S: Compliance with a class teaching breast self-examination. J Epidemiol Community Health 1983 (37–4):264–270PubMedCrossRefGoogle Scholar
  10. 10.
    Collette HJA, Day NE, Rombach JJ, de Waard F: Evaluation of screening for breast cancer in a non- randomised study (the DOM Project) by means of a case-control study. Lancet 1984 (i):1224–1225CrossRefGoogle Scholar
  11. 11.
    Day NE: Screening for Breast Cancer. Br Med Bull 1991 (47):400–415PubMedGoogle Scholar
  12. 12.
    Sasco AJ, Day NE, Walter SD: case-control studies for the evaluation of screening. J Chron Dis 1986 (39):399–405PubMedCrossRefGoogle Scholar
  13. 13.
    Moss SM: Case-control studies of screening. Int J Epidemiol 1991 (20):1–6PubMedCrossRefGoogle Scholar
  14. 14.
    Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F, Day NE: Reduction of breast cancer mortality through mass screening with modern mammograph: first results of the Nijmegen project, 1975–1981. Lancet 1984 (i):1222–1224CrossRefGoogle Scholar
  15. 15.
    Palli D, Rosselli del Turco M, Buiatti E, Carli S, Ciatto S, Toscani L, Maltoni GC: A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 1986 (38):501–504PubMedCrossRefGoogle Scholar
  16. 16.
    Palli D, Rosselli del Turco M, Buiatti E, Ciatto S, Crocetti E, Paci F: Time intervals since last test in a breast cancer screening programme: a case-control study in Italy. J Epidemiol Health 1989 (43):241–248CrossRefGoogle Scholar
  17. 17.
    Miller AB, Baines CJ, To T, Wall C: The Canadian National Breast Screening Study. In: Cancer Screening. Miller AB, Chamberlain J, Day NE (eds). Hakama M & Prorok PC. Cambridge University Press, 1991 pp 45–55Google Scholar
  18. 18.
    UKCCCR Subcommittee on Breast Screening Research, UKCCCR-sponsored Research on Breast Cancer Screening. J. Public Health Med. In pressGoogle Scholar
  19. 19.
    Tabar L, Fagerberg G, Day NE, Holmberg L: What is the optimum interval between mammography screening examinations? Br J Cancer 1987 (55):547–551PubMedCrossRefGoogle Scholar
  20. 20.
    de Waard F, Collette HJA, Rombach JJ, Bannders van Halewijn EA, Honing C: The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. J Chronic Dis 1984 (37–1):1–44PubMedCrossRefGoogle Scholar
  21. 21.
    Powles TJ, Hardy SE, Ashley GM, et al: A pilot trial to evalute the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 1989 (60):126–131PubMedCrossRefGoogle Scholar
  22. 22.
    Early Breast Cancer Trialists’ Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 1988 (319):1681–1692CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Jocelyn Chamberlain
    • 1
  • Domenico Palli
    • 2
  1. 1.The Institute of Cancer Research, Royal Cancer HospitalD H Cancer Screening Evaluation UnitSuttonUK
  2. 2.Centro per lo Studio e la Prevenzione OncologicaEpidemiology UnitFlorenceItaly

Personalised recommendations